Multidisciplinary collaboration is crucial for rheumatologist Laura Cappelli. Her recent study, conducted with Johns Hopkins oncologists, showed that patients with both an rheumatic disease and lung cancer who were diagnosed earlier had better survival outcomes compared to patients without such rheumatic conditions. Cappelli discussed her research in advance of a presentation at the American College of Rheumatology / Association of Rheumatology Professionals 2022 annual conference.
Video
Improved Overall Survival in Patients with Lung Cancer and Autoimmune Rheumatic Diseases
Resources for Clinicians
Clinicians, discover the latest in research and clinical innovation from Johns Hopkins experts. Access educational videos, articles, CME courses and other resources from our world-renowned institution.